SaaS Benchmarks by Stage: Seed to Series C

Most SaaS benchmark articles hand you a single number and call it universal. "Good churn is 5%." "Aim for 3:1 LTV:CAC." That framing is worse than useless — it actively misleads. A seed-stage company burning through its first $10K MRR and a Series C company defending $3M MRR operate in different universes with different physics. The same churn rate that signals product-market fit at seed signals structural decay at Series C. Stage-specific benchmarks exist, but they're scattered across twenty reports, each using different definitions and different time windows. This consolidates them into one reference, organized by what investors and operators actually need: the right number, for the right stage, with the context that makes it actionable.

Why stage matters more than industry

The instinct is to benchmark by vertical. "What's good churn for a healthcare SaaS?" Vertical matters, but it explains less variance than stage. A $30K MRR healthcare SaaS and a $30K MRR DevTools SaaS have more in common with each other than either has with a $2M MRR company in its own vertical. Both are fighting the same battles: establishing repeatable acquisition, proving the product retains, and building the unit economics that unlock the next round.

Stage is a proxy for three things that shape what metrics are possible. First, scale — a 50-customer company and a 2,000-customer company produce statistically different metric distributions even if the underlying business is identical. Second, maturity of go-to-market — founder-led sales produces different CAC and LTV than a scaled sales team. Third, investor expectations — what a seed investor needs to see is structurally different from what a growth-stage investor underwrites.

The practical consequence: applying Series B benchmarks to a seed company penalizes it for not having achieved things that are mathematically impossible at its scale. Applying seed benchmarks to a Series C company grades it on a curve it should have outgrown two rounds ago. Both produce wrong conclusions. Stage-adjusted benchmarks are the minimum viable context for any metric comparison.

Pre-seed and seed benchmarks

At seed, most SaaS metrics are noise. The customer base is under 50 accounts, MRR is typically $10K–$50K, and a single large win or loss swings every ratio by 20% or more. NRR is incalculable with fewer than 30 accounts. LTV:CAC is distorted by founder-led sales where the CEO is the sales team. Quick ratio oscillates wildly month to month.

That doesn't mean metrics don't matter at seed. It means different metrics matter. The signal at this stage is trajectory, not levels. Month-over-month MRR growth is the clearest indicator of product-market fit. Logo churn tells you whether early customers stick after the honeymoon period. Activation rate — what percentage of signups reach a meaningful usage threshold — predicts whether growth will compound or stall.

The burn multiple at seed deserves special attention. Early-stage companies are supposed to burn — that's what the capital is for. But a burn multiple above 5.0x means the company is spending five dollars for every dollar of net new ARR. At that rate, a $3M seed round produces $600K of ARR before the money runs out. That's not investing in growth; that's subsidizing an unsustainable business model. A burn multiple of 3.0–5.0x is the expected range. Below 3.0x at seed is genuinely impressive capital efficiency.

Series A benchmarks

Series A is where benchmark evaluation begins in earnest. The company should have 100–500 paying customers, $100K–$300K MRR, and enough cohort history — typically 12–18 months post-launch — to measure retention credibly. NRR becomes meaningful. LTV:CAC enters the picture, with a critical caveat about founder-led sales inflating the number.

The LTV:CAC caveat at Series A is important enough to state explicitly. If the CEO closed 30–40% of deals, the reported CAC dramatically understates the real cost of acquisition. You cannot hire a second CEO. Adjusting for this means estimating fully loaded CAC with a sales team that replaces the founder's direct selling effort. A reported 4:1 LTV:CAC at Series A with heavy founder involvement often adjusts to 2:1–2.5:1 — which is fine for the stage, but looks very different from the unadjusted number.

MRR growth of 10–15% month-over-month is the Series A healthy range. Below 10% raises the question of whether the company has hit a growth ceiling before scaling its go-to-market. Above 15% is strong — it suggests the company found a repeatable acquisition channel, not just a product people want but a way to reach them efficiently.

Series B benchmarks

By Series B, every metric should be measurable and trending. The company has $500K–$1.5M MRR, 500–2,000 customers, and at least two years of cohort data. The diagnostic shifts from "are the metrics healthy?" to "are the metrics improving?" A company with 107% NRR trending toward 115% over three quarters deserves more attention than one sitting stable at 112%.

NRR below 100% at Series B is a structural problem, not an early-stage artifact. The company has had enough time and enough customers to prove whether it can retain and expand revenue. If the existing base is shrinking, no amount of new logo acquisition produces a durable business. Investors at this stage look for expansion revenue contributing 25%+ of net new ARR — a sign that the product grows within accounts, not just across them.

The burn multiple becomes a serious evaluation criterion at Series B. The expected range compresses to 1.5–2.0x. A company still burning at 3.0x at this stage is spending three dollars for every dollar of net new ARR — an efficiency level that was acceptable two rounds ago and is no longer defensible. At 1.5–2.0x, the company demonstrates that growth is self-reinforcing rather than capital-dependent.

Series C and beyond

At Series C+, the business model should be proven. MRR sits at $2M–$5M+, the customer base is measured in thousands, and the company should be demonstrating a credible path to profitability or already operating near breakeven. The evaluation focus shifts to durability and market position — can the company maintain these metrics as it scales into new segments, geographies, or product lines?

A burn multiple below 1.0x at Series C means the company generates more net new ARR than it burns cash — it's approaching or already at positive unit economics on a per-dollar-of-growth basis. This is where the Rule of 40 becomes genuinely meaningful. At $2M+ MRR, the tradeoff between growth rate and margin is real and measurable. Below $10M ARR the Rule of 40 is noise. Above it, a score below 25 is bottom-quartile and suggests the company is neither growing fast nor operating efficiently.

The full cross-stage view

Seeing all four stages side by side reveals how benchmarks compress as companies mature. Growth rates decline, but efficiency expectations increase. Churn rates tighten. Retention expectations rise. The companies that look best at each stage are the ones outperforming on the metrics that matter most at that stage — growth at seed, retention at Series A, efficiency at Series B, and durability at Series C.

What separates top quartile from median

The gap between median and top-quartile performance is not evenly distributed across metrics. Some metrics show a 20–30% spread (MRR growth, churn). Others show a 2–3x spread (burn multiple, LTV:CAC). Understanding where the spread is widest tells you which metrics offer the most room for differentiation.

Burn multiple and LTV:CAC show the widest relative spreads, meaning efficiency metrics separate the best companies from the middle more sharply than growth metrics do. A Series A company growing at 12% MoM (median) versus 18% (top quartile) is 50% faster. A Series A company with a 2.5x burn multiple (median) versus 1.5x (top quartile) is nearly twice as efficient. The efficiency gap compounds more aggressively because it determines how much of each growth dollar translates to durable value.

The implication for both founders and investors: once growth rate clears the threshold for the stage, efficiency metrics are the tiebreaker. Two companies growing at 12% MoM will have very different outcomes depending on whether they do it at 1.5x or 3.0x burn multiple. The faster-growing company with worse efficiency often loses the long game to the slightly-slower company that retains more of every dollar.

How stage benchmarks change fundraising conversations

Fundraising conversations fail when founders and investors apply different benchmarks. A founder who pitches a 3% monthly churn rate as exceptional is right — if they're at seed. The same claim at Series B is table stakes. The disconnect produces a conversation where the founder thinks they're presenting strength and the investor hears "average."

Stage-appropriate benchmarks solve this by giving both sides a shared reference frame. When a Series A founder says "our NRR is 108%," the next question should be "where does that sit against Series A medians?" The answer — that 108% is above median but not top quartile — sets the right expectation. It's a healthy number with room to grow, not a superlative claim that needs to be defended.

For investors, stage-specific benchmarks sharpen portfolio construction. A seed fund evaluating 200 companies a year cannot apply Series B criteria without passing on every company. The filtering question is not "does this company have 115% NRR?" but "is this company's trajectory consistent with reaching 115% NRR by Series B?" That requires knowing what seed-stage trajectory typically leads to growth-stage outperformance — which is exactly what stage-adjusted benchmarks provide.

Tracking stage-appropriate benchmarks

The hardest part of stage-adjusted benchmarking is not the benchmark data — it's calculating the metrics consistently enough to compare against it. Self-reported MRR varies by definition. Churn calculations depend on whether reactivations count as new or returning. NRR depends on how mid-cycle plan changes are classified. Every company computes these slightly differently, which makes comparing against external benchmarks an exercise in estimation, not measurement.

North Metric connects directly to Stripe and derives every metric from billing events using a single, consistent methodology. MRR is normalized from all billing intervals. Churn is classified by subscription event type. NRR is computed with expansion, contraction, and churn separated at the invoice level. The result is metrics that are genuinely comparable against external benchmarks — because the definitions match.

For portfolio investors managing companies across multiple stages, the multi-company view applies stage-appropriate scoring automatically. A seed company with 18% month-over-month growth and a Series B company with 9% month-over-month growth can both score as "median" — because they are, for their respective stages. The alternative — a single benchmark that calls the seed company "strong" and the Series B company "weak" — produces exactly the kind of misleading signal that leads to bad capital allocation decisions.